LCID
Lucid Group, Inc.
LCID has the edge over PZZA overall, supported by stronger modeled upside and stronger fundamentals.
PZZA
Papa John's International, Inc.
PZZA trails on the overall score without a compensating advantage in the available component scores.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PZZA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
PZZA's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PZZA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 21x | $15.78 | -18% |
| Current | 25x | $19.16 | — |
| Fair | 33x | $25.26 | +32% |
| Expensive | 100x | $75.77 | +295% |
Historical ranges are pointers, not guarantees.
PZZA's PE is in its cheap range at 25x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PZZA Forward outlook
There aren't enough analyst estimates for PZZA to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PZZA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.76 | -33% |
| Q2 2026 | $0.80 | -65% |
| Q1 2026 | $0.84 | -65% |
| Q4 2025 | $0.90 | -65% |
| Q3 2025 | $1.14 | -61% |
| Q2 2025 | $2.28 | +8.6% |
| Q1 2025 | $2.37 | +4.4% |
| Q4 2024 | $2.54 | +2.4% |
PZZA has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PZZA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PZZA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $454.8M | -10% |
| Q2 2026 | $482.4M | -8.8% |
| Q1 2026 | $478.6M | -7.7% |
| Q4 2025 | $498.2M | -6.1% |
| Q3 2025 | $508.2M | +0.3% |
| Q2 2025 | $529.2M | +4.2% |
| Q1 2025 | $518.3M | +0.9% |
| Q4 2024 | $530.8M | -7.1% |
PZZA's revenue has slid since its 2023 peak: $455M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.1% | -0.1 points |
| Q2 2026 | 4.8% | +0.2 points |
| Q1 2026 | 4.3% | -0.3 points |
| Q4 2025 | 4.9% | -0.6 points |
| Q3 2025 | 3.2% | -9.7 points |
| Q2 2025 | 4.6% | -0.9 points |
| Q1 2025 | 4.6% | -1.9 points |
| Q4 2024 | 5.6% | -1.9 points |
PZZA has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PZZA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.7M | -57% |
| Q2 2026 | $15.7M | -9.9% |
| Q1 2026 | -$6.2M | -133% |
| Q4 2025 | $2.1M | -92% |
| Q3 2025 | $22.7M | +$26.5M |
| Q2 2025 | $17.4M | +26% |
| Q1 2025 | $19.1M | +$20.2M |
| Q4 2024 | $25.2M | -38% |
PZZA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PZZA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.1x | High |
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.8x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 3.2x | Elevated |
| Q4 2024 | 3.1x | Elevated |
PZZA's net debt is about 4.0 years of its operating earnings (EBITDA), about the same as a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PZZA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 13.3 | Oversold |
PZZA's weekly RSI is 30 (neutral) and its Stochastic is 13 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PZZA PE vs Consumer Cyclical Sector
| Metric | PZZA | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 18x | 40% above |
| PE % | 29 | 47 | 18 pts below |
PZZA is trading at 25x earnings, a 40% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PZZA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.2 | 0.2% below |
| 20 week MA | $23.8 | 19% below |
| 50 week MA | $30.8 | 38% below |
| 100 week MA | $37.2 | 48% below |
| 200 week MA | $51.4 | 63% below |
PZZA is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PZZA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $64.5 | $87.5 | +36% |
| 2021 | $87.5 | $132.6 | +51% |
| 2022 | $132.6 | $84.0 | -37% |
| 2023 | $84.0 | $76.2 | -9.2% |
| 2024 | $76.2 | $39.5 | -48% |
| 2025 | $39.5 | $39.3 | -0.5% |
| 2026 YTD | $39.3 | $19.2 | -51% |
PZZA has the edge over LCID on returns for 2026, with the stronger performance.